• linkedin
  • Increase Font
  • Sharebar

    Survey: Med synchronization programs improve adherence

     

    Findings

    Conducted in July 2014 by Langer Research Associates, the survey comprised random-sample telephone interviews with more than 1,000 ongoing medication users 40 years of age and older. The margin of error was 3.5.

    The survey found:

    ·      Among patients participating in medication synchronization programs, 83% find them “extremely or very” helpful in managing their medication refills.

    ·      Of patients enrolled in synchronization programs, 74% said the programs help them improve their overall medication adherence.

    ·      Medication synchronization enrollees were 10% more likely to be “highly satisfied” with their pharmacy.

    ·      Among survey respondents who were not enrolled in medication synchronization programs, 50% said they were “very” or “somewhat” interested in the programs.

    Star Ratings

    “Three out of the five quality measures used by the Centers for Medicare and Medicaid Services as part of a health plan’s Star Ratings are about adherence,” Hoey said. “To put it simply, community pharmacies that do a good job helping patients take their medications will be more likely to be included by health plans in their pharmacy networks.”

    NCPA offers a promotional toolkit to help pharmacies recruit patients for medication synchronization programs. It includes a sample news release, a customizable letter to the editor, sample social media posts, telephone scripts to be used by pharmacy staff, and a Power Point presentation that can be used in community outreach.

    Mark Lowery, Editor
    Mark Lowery an Editor for Drug Topics magazine.

    0 Comments

    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available